Quality, safety and sustained therapeutic efficacy of blood-derived serum eye drops to treat dry eye syndrome: R&D road map for future progress

Transfus Apher Sci. 2016 Feb;54(1):168-9. doi: 10.1016/j.transci.2016.01.023. Epub 2016 Jan 15.

Authors

Jerard Seghatchian¹, Aurora Espinosa², Thierry Burnouf³

Affiliations

¹ International Consultancy in Blood Components Quality/Safety, Audit/Inspection and DDR Strategies, London, UK. Electronic address: jseghatchian@btopenworld.com.
² Department of Immunology and Transfusion Medicine, St. Olav's University Hospital, Trondheim, Norway.
³ Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.

PMID: 26818750
DOI: 10.1016/j.transci.2016.01.023

No abstract available

Keywords: Dry eye syndromes; Quality/safety standard of SED; Sustained therapeutic efficacy of SED.

Publication types

Review

MeSH terms

Dry Eye Syndromes / drug therapy*
Humans
Ophthalmic Solutions / standards*
Ophthalmic Solutions / therapeutic use*
Research*
Safety*
Serum / metabolism*
Treatment Outcome

Substances

Ophthalmic Solutions